Who Supplies Fexofenadine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Fexofenadine exports, with 224+ registered manufacturers shipping to buyers across 97+ countries — yet a handful of companies dominate the shipments. GRANULES INDIA LIMITED holds the largest share at 13.2% (export value: $14.4M). Close behind, CIPLA LIMITED (9.1%, $10.0M). DR.REDDY'S LABORATORIES LTD (8.8%, $9.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Fexofenadine? Top Manufacturers & Their Buyers
Flow of Fexofenadine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Fexofenadine Supplier Network — Key Market Intelligence
The Fexofenadine export market from India is led by GRANULES INDIA LIMITED, which alone commands a 13.2% share, shipping $14.4M worth of product across 194 shipments. The second-largest exporter, CIPLA LIMITED, contributes $10.0M (9.1%) to the overall market. Combined, the top two suppliers alone account for 22.3% of all Fexofenadine exports, indicating a relatively concentrated supply base.
Across all 224 tracked manufacturers, the total Fexofenadine export value stands at $109.6M from 4.2K shipments. The market average shipment value is $25.9K. The single largest buyer relationship in terms of trade value is MOVIANTO UK LTD, receiving $7.6M worth of product.
The combined buyer network spans 22 named purchasing companies, including GRANULES CONSUMER HEALTH, GRANULES USA INC, GRANULES CONSUMER, H.ESSERS & ZONEN INTERNATIONAL TRAN, ALLOGA UK LTD and 17 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1GRANULES INDIA LIMITED
GRANULES INDIA LIMITED is the first-largest Fexofenadine exporter from India, with a market share of 13.2% and a total export value of $14.4M across 194 shipments. Their average shipment value of $74.5K is above the market average of $25.9K, suggesting premium or bulk contract pricing.
GRANULES INDIA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• GRANULES CONSUMER HEALTH — $5.8M across 78 shipments (40.4% of this supplier's total exports)
• GRANULES USA INC — $5.1M across 69 shipments (35.7% of this supplier's total exports)
• GRANULES USA INC — $3.0M across 40 shipments (20.8% of this supplier's total exports)
• GRANULES CONSUMER — $266.2K across 4 shipments (1.8% of this supplier's total exports)
• GRANULES CONSUMER HEALTH — $195.8K across 3 shipments (1.4% of this supplier's total exports)
Key Insight: GRANULES INDIA LIMITED's per-shipment value of $74.5K is 188% above the market average of $25.9K, consistent with large-order contracts or value-added formulations.
2CIPLA LIMITED
CIPLA LIMITED is the second-largest Fexofenadine exporter from India, with a market share of 9.1% and a total export value of $10.0M across 921 shipments. Their average shipment value of $10.8K is below the market average of $25.9K, reflecting a high-volume, competitive pricing strategy.
CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• H.ESSERS & ZONEN INTERNATIONAL TRAN — $3.9M across 362 shipments (39.3% of this supplier's total exports)
• ALLOGA UK LTD — $3.6M across 336 shipments (36.5% of this supplier's total exports)
• NOUMED PHARMACEUTICALS PTY LTD — $1.9M across 177 shipments (19.2% of this supplier's total exports)
• BREATHEFREE LANKA PV — $288.7K across 27 shipments (2.9% of this supplier's total exports)
• NOUMED PHARMACEUTICALS PTY LTD — $204.0K across 19 shipments (2.0% of this supplier's total exports)
Key Insight: CIPLA LIMITED operates with high shipment frequency (921 shipments) at a per-shipment value of $10.8K, indicating a broad distribution network with many smaller, regular orders.
3DR.REDDY'S LABORATORIES LTD
DR.REDDY'S LABORATORIES LTD is the third-largest Fexofenadine exporter from India, with a market share of 8.8% and a total export value of $9.6M across 249 shipments. Their average shipment value of $38.7K is above the market average of $25.9K, suggesting premium or bulk contract pricing.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. MOVIANTO UK LTD is the dominant customer, accounting for 78.5% of this supplier's tracked business. Top customers include:
• MOVIANTO UK LTD — $7.6M across 195 shipments (78.5% of this supplier's total exports)
• MOVIANTO UK LTD — $1.7M across 44 shipments (17.7% of this supplier's total exports)
• REED - LANE INC 359 — $220.1K across 6 shipments (2.3% of this supplier's total exports)
• DR.REDDY'S LABORATOR — $88.6K across 2 shipments (0.9% of this supplier's total exports)
• DR.REDDYS NEWZEALAND — $56.5K across 1 shipments (0.6% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $38.7K is 50% above the market average of $25.9K, consistent with large-order contracts or value-added formulations.
4IND SWIFT LIMITED
IND SWIFT LIMITED is the fourth-largest Fexofenadine exporter from India, with a market share of 7.4% and a total export value of $8.1M across 524 shipments. Their average shipment value of $15.5K is below the market average of $25.9K, reflecting a high-volume, competitive pricing strategy.
IND SWIFT LIMITED serves 5 named buyers in our database. CHANELLE MEDICAL is the dominant customer, accounting for 68.1% of this supplier's tracked business. Top customers include:
• CHANELLE MEDICAL — $5.5M across 357 shipments (68.1% of this supplier's total exports)
• APOTEX PTY LTD — $1.0M across 66 shipments (12.6% of this supplier's total exports)
• KENT PHARMA UK LTD — $686.1K across 44 shipments (8.4% of this supplier's total exports)
• ASCEND LABORATORIES — $572.4K across 37 shipments (7.0% of this supplier's total exports)
• GOLDPLUS UNIVERSAL P — $305.5K across 20 shipments (3.8% of this supplier's total exports)
Key Insight: IND SWIFT LIMITED operates with high shipment frequency (524 shipments) at a per-shipment value of $15.5K, indicating a broad distribution network with many smaller, regular orders.
5DR REDDYS LABORATORIES LIMITED
DR REDDYS LABORATORIES LIMITED is the fifth-largest Fexofenadine exporter from India, with a market share of 5.4% and a total export value of $5.9M across 62 shipments. Their average shipment value of $94.7K is above the market average of $25.9K, suggesting premium or bulk contract pricing.
DR REDDYS LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MOVIANTO UK LIMITED — $2.7M across 28 shipments (46.0% of this supplier's total exports)
• DR REDDYS LABORATORIES INC — $1.9M across 20 shipments (32.7% of this supplier's total exports)
• REED-LANE INC — $691.5K across 7 shipments (11.8% of this supplier's total exports)
• MOVIANTO UK LTD — $412.1K across 4 shipments (7.0% of this supplier's total exports)
• REED-LANE INC — $149.3K across 2 shipments (2.5% of this supplier's total exports)
Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $94.7K is 266% above the market average of $25.9K, consistent with large-order contracts or value-added formulations.
6SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Fexofenadine exporter from India, with a market share of 5.3% and a total export value of $5.8M across 154 shipments. Their average shipment value of $37.8K is above the market average of $25.9K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• OHM LABORATORIES INC — $2.0M across 52 shipments (33.5% of this supplier's total exports)
• AO RANBAXY — $1.4M across 38 shipments (24.6% of this supplier's total exports)
• OHM LABORATORIES INC — $1.1M across 29 shipments (18.9% of this supplier's total exports)
• AO RANBAXY — $813.0K across 21 shipments (14.0% of this supplier's total exports)
• M/S. RANBAXY FARMACE — $527.7K across 14 shipments (9.1% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $37.8K is 46% above the market average of $25.9K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Fexofenadine Flows
Once Fexofenadine leaves the manufacturing plants of companies like GRANULES INDIA LIMITED and CIPLA LIMITED, it travels to 5 destination markets with a combined import value of $109.6M. United Kingdom absorbs the largest share at 30.8% ($33.8M), followed by United States (26.9%) and Ireland (10.0%).
In United Kingdom — the top destination — named importers include MOVIANTO UK LTD, MOVIANTO UK LIMITED, ALLOGA UK LTD. In United States, key buyers are GRANULES USA INC, GRANULES CONSUMER HEALTH, GRANULES USA INC..
This geographic spread reflects Fexofenadine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Fexofenadine Go? Top Importing Countries & Their Buyers
Trade flow of Fexofenadine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United Kingdom
United Kingdom ranks as the first-largest destination for Fexofenadine imports from India, with a total trade value of $33.8M across 691 shipments — representing a 30.8% share of all Fexofenadine exports. The average shipment value of $48.9K is above the global average of $25.9K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.
Named Fexofenadine importers in United Kingdom: MOVIANTO UK LTD is the largest buyer, accounting for 32.6% ($11.0M) of this market's total imports.
• MOVIANTO UK LTD — $11.0M (32.6% of United Kingdom's total)
• MOVIANTO UK LIMITED — $5.4M (16.1% of United Kingdom's total)
• ALLOGA UK LTD — $4.3M (12.6% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $48.9K (89% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Fexofenadine imports from India.
2United States
United States ranks as the second-largest destination for Fexofenadine imports from India, with a total trade value of $29.5M across 271 shipments — representing a 26.9% share of all Fexofenadine exports. The average shipment value of $108.9K is above the global average of $25.9K, indicating high-value procurement contracts or branded formulations. This market is served by 6 tracked buyers.
Named Fexofenadine importers in United States: GRANULES USA INC is the largest buyer, accounting for 25.2% ($7.4M) of this market's total imports.
• GRANULES USA INC — $7.4M (25.2% of United States's total)
• GRANULES CONSUMER HEALTH — $5.8M (19.8% of United States's total)
• GRANULES USA INC. — $3.3M (11.3% of United States's total)
Key Insight: United States's per-shipment average of $108.9K (321% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Fexofenadine imports from India.
3Ireland
Ireland ranks as the third-largest destination for Fexofenadine imports from India, with a total trade value of $11.0M across 358 shipments — representing a 10.0% share of all Fexofenadine exports. The average shipment value of $30.6K is above the global average of $25.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Fexofenadine importers in Ireland: CHANELLE MEDICAL is the largest buyer, accounting for 95.5% ($10.5M) of this market's total imports.
• CHANELLE MEDICAL — $10.5M (95.5% of Ireland's total)
Key Insight: Ireland's per-shipment average of $30.6K (18% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ireland is a key market for Fexofenadine imports from India.
4Australia
Australia ranks as the fourth-largest destination for Fexofenadine imports from India, with a total trade value of $8.8M across 366 shipments — representing a 8.1% share of all Fexofenadine exports. The average shipment value of $24.1K is below the global average of $25.9K, consistent with generic/API volume purchasing. This market is served by 3 tracked buyers.
Named Fexofenadine importers in Australia: NOUMED PHARMACEUTICALS PTY LTD is the largest buyer, accounting for 31.6% ($2.8M) of this market's total imports.
• NOUMED PHARMACEUTICALS PTY LTD — $2.8M (31.6% of Australia's total)
• MEDREICH AUSTRALIA PTY LTD — $1.4M (15.5% of Australia's total)
• APOTEX PTY LTD — $1.3M (14.7% of Australia's total)
Key Insight: Australia receives frequent, smaller shipments of Fexofenadine — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Australia is a key market for Fexofenadine imports from India.
5Belgium
Belgium ranks as the fifth-largest destination for Fexofenadine imports from India, with a total trade value of $5.0M across 166 shipments — representing a 4.6% share of all Fexofenadine exports. The average shipment value of $30.2K is above the global average of $25.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Fexofenadine importers in Belgium: H.ESSERS & ZONEN INTERNATIONAL TRAN is the largest buyer, accounting for 84.5% ($4.2M) of this market's total imports.
• H.ESSERS & ZONEN INTERNATIONAL TRAN — $4.2M (84.5% of Belgium's total)
Key Insight: Belgium's per-shipment average of $30.2K (17% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Fexofenadine imports from India.
People Also Ask — Fexofenadine Supplier & Trade Network
Who are the top suppliers of Fexofenadine from India?+
Which companies buy Fexofenadine from Indian manufacturers?+
Where does Fexofenadine exported from India go?+
What is the market share of the top Fexofenadine supplier from India?+
What is the average shipment value for Fexofenadine exports from India?+
Is Fexofenadine manufactured in India and exported globally?+
Which country imports the most Fexofenadine from India?+
Who are the buyers of Fexofenadine in United States?+
How concentrated is the Fexofenadine supplier market in India?+
How do I find verified buyers for Fexofenadine in specific countries?+
Fexofenadine Trade Network — Key Takeaways
- 1GRANULES INDIA LIMITED is India's dominant Fexofenadine exporter with a 13.2% market share and $14.4M in total exports — making it the single most important sourcing entity in this market.
- 2The top 224 suppliers collectively account for 49.2% of all tracked Fexofenadine exports, with a combined trade value of $109.6M.
- 3United Kingdom is the largest destination market, absorbing 30.8% of India's Fexofenadine exports ($33.8M). United States (26.9%) and Ireland (10.0%) follow.
- 4With 4.2K total shipments averaging $25.9K each, the Fexofenadine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include GRANULES CONSUMER HEALTH, GRANULES USA INC, H.ESSERS & ZONEN INTERNATIONAL TRAN, ALLOGA UK LTD — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 97 countries
Network value: $109.6M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fexofenadine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Fexofenadine.
- 2.Flow Mapping: 224 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,236 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 97 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,236 Verified Shipments
224 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists